Advertisement
Screener

CARDLYTICS, INC. (CDLX) Sale of Stock, Consideration Received on Transaction

CARDLYTICS, INC. Sale of Stock, Consideration Received on Transaction

CARDLYTICS, INC. (CDLX) reported Sale of Stock, Consideration Received on Transaction of $23.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Notes › Equity

us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2026-08-05

  • 2026-06-30: Sale of Stock, Consideration Received on Transaction 6 month $23.00M.
Period endSale of Stock, Consideration Received on Transaction 6 month
2026-06-30$23.00M
10-Q · filed 2026-08-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM)United States$0.016B-4.22
Global Interactive Technologies, Inc. (GITS)$0.008B
TaoWeave, Inc. (TWAV)United States$0.006B
ZW Data Action Technologies Inc. (CNET)$0.005B-5.46
AIRWA INC. (YYAI)United States$0.004B-101.45
Teads Holding Co. (TEAD)United States$0.045B-0.14
Professional Diversity Network, Inc. (IPDN)United States$0.060B
PodcastOne, Inc. (PODC)United States$0.068B-42.98
Eva Live Inc (GOAI)United States$0.083B
Health Catalyst, Inc. (HCAT)United States$0.132B-0.56